module 205.4 20_a_en
TRANSCRIPT
![Page 1: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/1.jpg)
DIABETIC NEUROPATHY AND PERIPHERAL VASCULAR DISEASE
![Page 2: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/2.jpg)
Objectives
![Page 3: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/3.jpg)
Diabetic foot disease - the high-risk foot
![Page 4: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/4.jpg)
Some statistics
![Page 5: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/5.jpg)
Prevention
![Page 6: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/6.jpg)
Activity
![Page 7: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/7.jpg)
Peripheral neuropathy - sensory motor
![Page 8: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/8.jpg)
Diabetic peripheral neuropathy – risk factors
![Page 9: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/9.jpg)
Nerve damage - neuropathy
![Page 10: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/10.jpg)
![Page 11: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/11.jpg)
Painless nature of diabetic foot disease
![Page 12: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/12.jpg)
Sensory nerve damage
![Page 13: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/13.jpg)
Motor nerve damage
![Page 14: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/14.jpg)
Localised callus
![Page 15: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/15.jpg)
Autonomic nerve damage
![Page 16: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/16.jpg)
Foot assessment
![Page 17: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/17.jpg)
Screening tests for peripheral neuropathy
![Page 18: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/18.jpg)
Assessment of high risk characteristics
![Page 19: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/19.jpg)
Charcot’s arthropathy
![Page 20: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/20.jpg)
Acute vs chronic Charcot’s arthropathy
![Page 21: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/21.jpg)
Charcot’s arthropathy
![Page 22: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/22.jpg)
Charcot’s arthropathy - treatment
![Page 23: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/23.jpg)
Risk categorisation system
![Page 24: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/24.jpg)
Peripheral Vascular Disease
![Page 25: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/25.jpg)
Peripheral vascular disease
![Page 26: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/26.jpg)
Peripheral vascular disease in diabetes
![Page 27: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/27.jpg)
Characteristics of atherosclerosis in diabetes
![Page 28: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/28.jpg)
Peripheral vascular disease
![Page 29: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/29.jpg)
Signs of vascular disease
![Page 30: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/30.jpg)
Peripheral vascular disease and diabetes
![Page 31: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/31.jpg)
Vascular assessment
![Page 32: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/32.jpg)
Peripheral vascular disease non-invasive evaluation (1 of 2)
![Page 33: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/33.jpg)
Peripheral vascular disease non-invasive evaluation (2 of 2)
![Page 34: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/34.jpg)
Peripheral vascular disease
![Page 35: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/35.jpg)
Cause of diabetic amputation
![Page 36: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/36.jpg)
85% of amputations are preventable!
![Page 37: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/37.jpg)
Activity
![Page 38: Module 205.4 20_a_en](https://reader035.vdocuments.mx/reader035/viewer/2022062903/58e49c511a28abf5428b53b1/html5/thumbnails/38.jpg)
References